no metadatahttps://benchmarkantibodies.com/product-tag/amacr/
Skip to content

Showing all 5 results

AMACR

AMACR (Alpha-Methylacyl-CoA Racemase): AMACR is an important marker in prostate pathology, particularly for distinguishing between benign prostatic hyperplasia and prostate cancer. Elevated AMACR expression is associated with malignant transformation, making it a valuable diagnostic tool when assessing prostatic tissues, especially in needle biopsy specimens.



targettypereactivityapplications
No products found

Human prostate carcinoma stained anti-AMACR antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands.
IHC with antibody [6017] : Human prostate carcinoma stained anti-AMACR antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands.
Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
IHC with antibody [6018] : Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.
IHC with antibody [6019] : Human prostate carcinoma stained anti-AMACR and anti-p63 antibodies using peroxidase-conjugate and DAB chromogen. Note cytoplasmic and luminal circumferential staining of carcinoma glands with AMACR and basal cell nuclear staining with p63.